期刊文献+

细胞凋亡在熄风止颤合剂治疗PSI诱导的帕金森病中的作用

The Role of Apoptosis in the Treatment of Parkinson's Disease Induced by PSI with Xifengzhichan Mixture
下载PDF
导出
摘要 目的观察熄风止颤合剂对蛋白酶抑制因子(PSI)诱导的帕金森病慢性动物模型大鼠的治疗作用,探讨熄风止颤合剂对帕金森病治疗的细胞凋亡机制。方法雄性sD大鼠背部皮下注射PSI,制备慢性帕金森病动物模型,将造模成功大鼠随机分为3组:分别以生理盐水、美多巴及熄风止颤合剂进行灌胃治疗,观察其行为变化,并分别通过Tunel法、免疫组织化学的方法观察大鼠脑多巴胺神经元的变化。结果中药熄风止颤合剂可以改善帕金森病的症状,且中药组大鼠大脑中多巴胺神经元的密度高于美多巴组,细胞凋亡指数低于美多巴组。结论熄风止颤合剂对帕金森病有治疗作用,其作用可能是通过降低多巴胺神经元的凋亡。 Objective To observe the therapeutic effect of Xifengzhichan(xfzch) mixture for rats model with chronic Parkin's disease induced by PSI,and investigate the apoptosis mechanism of therapeutic effect. Methods Male Sprague-Dawley rats were used to establish the model of Parkinson's disease by hypodermic injection of PSI on their back. The model rats were randomly divided into three groups and were administrated saline, madopar and the traditional Chinese medicine by gavage respectively. The change of behavior was observed. To investigate the change of dopaminergic neuron of rats brain, tunnel and immunohistochemistry were used. Results Xfzhch mixture can improve the behavior of Parkin, s disease and the density of dopaminergie nueron in traditional Chinese medicine group was higher than madopar group but apoptosis index is lower. Conclusion Xfzhch mixture is effective for Parkin's disease and maybe it reduce the apoptosis of madopar neuron.
出处 《潍坊医学院学报》 2010年第3期189-191,共3页 Acta Academiae Medicinae Weifang
基金 山东省中医药科技发展计划资助项目(2007-154)
关键词 帕金森病 PSI 熄风止颤合剂 美多巴 多巴胺神经元 Parkin's disease PSI Xifengzhichan mixture Madopar Dopaminergic neuron
  • 相关文献

参考文献7

二级参考文献21

  • 1苏颖,曹学兵,孙圣刚,徐岩.左旋多巴治疗对帕金森病大鼠纹状体强啡肽原表达的影响[J].中国康复,2004,19(3):142-144. 被引量:4
  • 2陈生弟,中华神经精神科杂志,1990年,23卷,23页
  • 3陈生弟,中华医学杂志,1990年,70卷,252页
  • 4Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease[J]. Annu Rev Neurosci, 1999, 22:123- 144.
  • 5McNaught KSP, Perl DP, Brownell AL, et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinsen's disease[J]. Ann Neurol, 2004, 56:149- 162.
  • 6Meissner W, Hill MP, Tison F, et al. Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials[J]. Trends Pharmacol Sci, 2004, 25(5) : 249 - 253.
  • 7Petrucelli L, O' farrell C, Lockhart PJ, et al. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons [ J ].Neuron, 2002, 36: 1007- 1019.
  • 8Fornai F, Lenzi P, Gesi M, et al. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after protesome inhibition[J]. J Neurosci, 2003, 23 : 8955 - 8966.
  • 9SEATON AT,COOPER JM,SCHAPIRA AH.Cyclosporin Inhibition of Apoptosis Induced by Mitochondrial ComplexI Toxins[J].Brain Res(S0165-3806),1998,809:12-19.
  • 10CHOI WS,YOON SY,OH TH,et al.Two Distinct Mechanisms are Involved in 6-hydroxydopamine and MPTP Induced Dopaminergic Neuronal Cell Death:Role of Caspases,ROS[J].J Neurosci Res (S0360-4012),1999,57(1):86-94.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部